title: Controversy still swirls around FDA user fees: since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals--but does speed equal safety?
authors.forename: Kurt
authors.initials: K
authors.lastname: Ullman
mesh_terms: D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D055553:Prescription Drugs / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000331:legislation & jurisprudence*
chemical_list: D055553:Prescription Drugs